MD08
MD08 is an inhibitor of Aβ42 fibrillization and Tau aggregation. MD08 improves recognition memory and learning/memory abilities in Aβ-induced cognitive decline mouse models. MD08 does not impair motor coordination in Aβ-injected mice. MD08 has no anticancer activity against neuroblastoma. MD08 can be used for research on Alzheimer's disease.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C21H20Br2N2O3
- 分子量:508.20
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
体外実験
MD08 (50 μM; 5 h) suppresses Aβ42 fibril formation, as shown by reduced and smaller aggregates in TEM images[1].
MD08 (100-200 μM; 72 h) inhibits heparin-induced tau aggregation in a concentration-dependent manner, reaching approximately 75% inhibition at 200 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SH-SY5Y
-
Concentration:50 μM
-
Incubation Time:24 h
-
Result:Did not exhibit any significant cytotoxic effects compared with the control group.
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Swiss albino (25-40 g)[1]
-
Dosage:2 mg/kg, 5 mg/kg, and 10 mg/kg
-
Administration:i.p.; 14 days
-
Result:In the elevated plus maze test, % ITL was reduced to approximately 45% at 2 mg/kg, approximately 40% at 5 mg/kg, and 25% at 10 mg/kg.
In the novel object recognition test, the 2 mg/kg dose did not improve the discrimination index, while 5 mg/kg and 10 mg/kg produced higher discrimination index values.
In the rotarod test, 10 mg/kg did not impair motor coordination.
化学情報
-
分子量 508.20
-
分子式 C21H20Br2N2O3
-
SMILES
BrC1=CC=C(Br)C(CCC(C(NCCC2=CNC3=C2C=C(OC)C=C3)=O)=O)=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)